U.S. Antidepressant Sales Down:
$9.4b From $12b Peak in 2008


Antidepressants are still the most consumed class of medication in the U.S., with 270 million prescriptions per year. But sales revenue has gone down, to $9.4 billion, from a 2008 peak of $12 billion.  Lower-priced generics now account for 85% of prescriptions, and 40% of the market in terms of revenue, with branded pharmaceutical companies withdrawing from the antidepressant market as their patents expire.

Article →

Previous articleUN Prohibition of Psychiatric Commitment: Review and Analysis
Next articleSchizophrenia as Stress-Induced Dopamine Supersensitivity
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].